In 2022, the size of the European viscosupplementation market was estimated to be USD 4.49 billion. The market is anticipated to be valued at USD 4.91 billion by the end of 2023. By 2033, the European viscosupplementation market is projected to grow at a compound annual growth rate (CAGR) of 9.37% to reach a value of USD 12.03 billion.
Key Market Trends and Highlights
- Holistic wellness approach Some European wellness centers emphasize pain management and mental health, diet, and lifestyle changes as part of holistic wellness programs that represent a whole approach to joint health, including viscosupplementation.
- Better quality of life When considering viscosupplementation therapies, European patients frequently prioritize enhancing their overall quality of life since the treatment provides pain relief and the capacity to live an active and satisfying lifestyle.
- Diverse product portfolio A wide variety of viscosupplementation solutions, including hyaluronic acid formulations and injection schedules made to match the individual needs of patients, are available on the market, encouraging the use of individualized treatment plans.
Competitive Landscape
The need for cryotherapy technologies is anticipated to increase in the Europe region as a result of major manufacturers using cutting-edge technology in their viscosupplementation production. Some of the prominent developments by the important companies in this domain are provided below.
Key companies profiled
- Anika Therapeutics Inc.
- Sanofi S.A.
- Zimmer Biomet Holdings
- Meda AB
- Ferring B.V
- Fidia Pharmaceutici S.p.A
- Bioventus LLC
- Teva Pharmaceutical Industries Ltd.
- VIRCHOW BIOTECH
- Lifecore Biomedical
A Full Report Analysis
Segmentation Analysis of the Europe Viscosupplementation Market
By Product:
- Single Injection
- Three Injection
- Five Injection
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
By Region:
- Western Europe
- Eastern Europe
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
